Akio Ejima
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Synthetic Organic Chemistry Methods
Papers in
-
- Synthesis and biological activity 11
- Synthesis and Biological Evaluation 9
- Synthesis of β-Lactam Compounds 4
- Synthesis and Reactivity of Heterocycles 4
- Quinazolinone synthesis and applications 3
-
- Cancer therapeutics and mechanisms 17
- Co-authors
- Masamichi Sugimori (13 shared papers)Hirofumi Terasawa (8 shared papers)Satoru Ohsuki (10 shared papers)Ikuo Mitsui (7 shared papers)Eiji Kumazawa (5 shared papers)Keiki Sato (5 shared papers)Hiroaki Tagawa (8 shared papers)Kouichi Uoto (3 shared papers)
In The Last Decade
Akio Ejima
28 papers receiving 707 citations
Peers
Comparison fields: 5 of 68
- Toxicology 113
- Organic Chemistry 313
- Oncology 204
- Molecular Biology 479
- Pharmacology 82
Countries citing papers authored by Akio Ejima
This map shows the geographic impact of Akio Ejima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akio Ejima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akio Ejima more than expected).
Fields of papers citing papers by Akio Ejima
This network shows the impact of papers produced by Akio Ejima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akio Ejima. The network helps show where Akio Ejima may publish in the future.
Co-authors
The 25 scholars most cited alongside Akio Ejima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 134 | |
| 2 | 1996 | 117 | |
| 3 | 2000 | 53 | |
| 4 | 1969 | 50 | |
| 5 | 1994 | 39 | |
| 6 | 1989 | 31 | |
| 7 | 2002 | 30 | |
| 8 | 2002 | 29 | |
| 9 | 1990 | 29 | |
| 10 | 1998 | 29 | |
| 11 | 1999 | 24 | |
| 12 | 1993 | 23 | |
| 13 | 1997 | 21 | |
| 14 | 2005 | 21 | |
| 15 | 2004 | 20 | |
| 16 | 2002 | 20 | |
| 17 | 1992 | 17 | |
| 18 | 1994 | 16 | |
| 19 | 1987 | 11 | |
| 20 | Antiproliferative activity and mechanism of action of DZ-3358, a novel pyrimidinyl pyrazole derivative. | 2000 | 10 |
About Akio Ejima
Akio Ejima is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Toxicology and Pharmacology, having authored 30 papers that have together received 763 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (17 papers), Synthesis and biological activity (11 papers), Synthesis and Biological Evaluation (9 papers), Bioactive Compounds and Antitumor Agents (4 papers), Synthesis of β-Lactam Compounds (4 papers), Synthesis and Reactivity of Heterocycles (4 papers), Quinazolinone synthesis and applications (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Toxicology (113 citations), Organic Chemistry (313 citations), Oncology (204 citations), Molecular Biology (479 citations) and Pharmacology (82 citations). Akio Ejima has collaborated with scholars based in Japan and Germany. Frequent co-authors include Masamichi Sugimori, Hirofumi Terasawa, Satoru Ohsuki, Ikuo Mitsui, Eiji Kumazawa, Keiki Sato, Hiroaki Tagawa, Kouichi Uoto, Yungling Leo Lee and Shoji Yahara. Their work appears in journals such as Chemical and Pharmaceutical Bulletin, The Journal of Antibiotics, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry and Bulletin of the Chemical Society of Japan.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.